Filing Details
- Accession Number:
- 0001110803-14-000203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-03 20:05:59
- Reporting Period:
- 2014-06-02
- Filing Date:
- 2014-06-03
- Accepted Time:
- 2014-06-03 20:05:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566173 | Michel Bouchard | 5200 Illumina Way San Diego CA 92122 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-02 | 632 | $69.34 | 25,681 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-02 | 200 | $154.39 | 25,481 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-02 | 232 | $155.80 | 25,249 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-02 | 200 | $156.81 | 25,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-02 | 300 | $154.31 | 24,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-02 | 559 | $155.98 | 24,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-06-02 | 632 | $0.00 | 632 | $69.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,050 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 200 shares sold ranging from $154.05 to $154.735 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 232 shares sold ranging from $155.45 to $156.15 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $156.45 to $157.17 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $153.45 to $154.92 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 559 shares sold ranging from $155.45 to $156.41 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
